Stay updated with breaking news from Tom Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello, and welcome to the AIM ImmunoTech Quarterly Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
Tom Equels suffered serious injuries in an October 2021 horse accident. But he bounced back to continue his work and martial arts training.
Operator: Hello, and welcome to the AIM ImmunoTech Inaugural Fiscal Year 2022 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
AIM ImmunoTech Inc (NYSE:AIM) CEO Tom Equels provided a summary of positive clinical data supporting the synergistic potential of its flagship drug Ampligen...
Long-haul Covid patients put hope in experimental drugs Representational image Sumathi Reddy , The Wall Street Journal Share Via Read Full Story Patrick Varnes has suffered from shortness of breath, fatigue and headaches for about six months since being diagnosed with Covid at the end of June. The 41-year-old financial director in Atlanta says he has tried nearly 30 different supplements, acupuncture and a steroid. When he heard in an online support group about an experimental drug intended to treat long-term symptoms of Covid, he reached out to a doctor, and hopes to participate in a clin...